MedPath

Yoga for Patients With Irritable Bowel Syndrome

Not Applicable
Completed
Conditions
Irritable Bowel Syndrome
Registration Number
NCT02721836
Lead Sponsor
Universität Duisburg-Essen
Brief Summary

The proposed study aims to investigate the feasibility, effectiveness, and perceived benefit of a hatha yoga intervention for patients with irritable bowel syndrome (IBS) compared to nutrition counselling. Further, the potential of both interventions to influence the gut microbiome will be inquired.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
59
Inclusion Criteria
  • Patients with irritable bowel syndrome (IBS) diagnosed by physician and confirmed by Rome III diagnostic criteria
Exclusion Criteria
  • inflammatory bowel diseases (IBD)
  • total abdominal colectomy
  • no sonographie or colonoscopy as diagnostic criterion
  • stool lactoferrin > 7mg/g
  • pregnancy or breast feeding
  • simultaneous participation in further clinical intervention trials
  • Regular yoga practice or nutrition counselling in the past 12 months
  • Planned surgery in the study period
  • Serious illness that would interfere with the ability to practice yoga

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Irritable Bowel Syndrome SymptomsWeek 12

Irritable Bowel Syndrome Severity Scoring System (IBS-SSS)

Secondary Outcome Measures
NameTimeMethod
Emotional distressWeek 24

Hospital Anxiety and Depression Scale (HADS)

Subjective improvement of symptomsWeek 24

Adequate Relief Score and Global Improvement Scale (GI)

Irritable Bowel Syndrome SymptomsWeek 24

Irritable Bowel Syndrome Severity Scoring System (IBS-SSS)

Subjective StressWeek 24

Cohen Perceived Stress Scale (CPSS)

disease specific quality of lifeWeek 24

Irritable Bowel Syndrome Quality of Life measurement (IBS-QOL)

Generic Health-related Quality of lifeWeek 24

Short Form 36 Health Survey Questionnaire, SF-36

Gut microbiomeWeek 12

Stool samples

Adverse EventWeek 24

Trial Locations

Locations (1)

Universität Duisburg-Essen

🇩🇪

Essen, Germany

Universität Duisburg-Essen
🇩🇪Essen, Germany

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.